Cemex S.A.B. de C.V. (NYSE:CX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Cemex has a consensus “Moderate Buy” rating from 12 analysts, with seven buy ratings and five holds. The average 12-month price target is $13.07, above the reported share price of $10.20.
• Cemex recently reported quarterly EPS of $0.24 on $4.59 billion in revenue, while analysts forecast full-year EPS of $0.91. The stock was trading down 2.4%, with a market capitalization of approximately $14.77 billion.
• The company declared a quarterly dividend of $0.0312 per share, equivalent to an annualized $0.12 dividend and a 1.2% yield. Institutional investors own approximately 82.97% of Cemex’s outstanding shares.

Shares of Cemex S.A.B. de C.V. (NYSE:CX - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the twelve research firms that are presently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $13.0667.

A number of research analysts have issued reports on CX shares. Royal Bank Of Canada boosted their target price on Cemex from $12.75 to $13.50 and gave the company a "sector perform" rating in a research note on Friday, July 24th. Barclays raised their price target on Cemex from $15.00 to $16.00 and gave the stock an "overweight" rating in a research report on Friday, July 24th. Santander upgraded Cemex to an "outperform" rating in a report on Thursday, June 11th. Wall Street Zen lowered Cemex from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Finally, JPMorgan Chase & Co. increased their target price on Cemex from $14.50 to $15.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 8th.

Cemex Trading Down 2.4%

Shares of NYSE CX opened at $10.20 on Wednesday. Cemex has a twelve month low of $8.73 and a twelve month high of $13.67. The stock has a market cap of $14.77 billion, a price-to-earnings ratio of 29.99 and a beta of 1.52. The company has a quick ratio of 0.68, a current ratio of 0.92 and a debt-to-equity ratio of 0.44. The company's fifty day moving average is $11.49 and its 200-day moving average is $11.85.

Cemex (NYSE:CX - Get Free Report) last released its quarterly earnings data on Tuesday, June 30th. The construction company reported $0.24 EPS for the quarter. The business had revenue of $4.59 billion during the quarter. Cemex had a net margin of 2.83% and a return on equity of 3.82%. Equities research analysts predict that Cemex will post 0.91 EPS for the current year.

Cemex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 24th. Shareholders of record on Tuesday, September 15th will be paid a $0.0312 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $0.12 dividend on an annualized basis and a yield of 1.2%. Cemex's payout ratio is presently 35.29%.

Insider Buying and Selling at Cemex

In other news, VP De La Garza Oscar Bal Elizondo sold 212,680 shares of the company's stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $10.68, for a total value of $2,271,422.40. Following the completion of the transaction, the vice president owned 289,490 shares in the company, valued at $3,091,753.20. This represents a 42.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On Cemex

A number of hedge funds and other institutional investors have recently made changes to their positions in CX. Sei Investments Co. increased its holdings in Cemex by 7.4% during the 1st quarter. Sei Investments Co. now owns 4,150,537 shares of the construction company's stock worth $47,482,000 after purchasing an additional 287,350 shares in the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Cemex by 3.1% in the fourth quarter. BNP Paribas Financial Markets now owns 4,136,409 shares of the construction company's stock valued at $47,527,000 after purchasing an additional 124,420 shares in the last quarter. Lazard Asset Management LLC lifted its holdings in shares of Cemex by 14.4% in the first quarter. Lazard Asset Management LLC now owns 4,046,527 shares of the construction company's stock valued at $46,292,000 after purchasing an additional 508,016 shares in the last quarter. Letko Brosseau & Associates Inc. boosted its position in shares of Cemex by 3.4% during the fourth quarter. Letko Brosseau & Associates Inc. now owns 3,823,500 shares of the construction company's stock worth $43,932,000 after buying an additional 125,975 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of Cemex by 1,747.0% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,646,000 shares of the construction company's stock worth $41,710,000 after buying an additional 3,448,600 shares during the period. 82.97% of the stock is currently owned by institutional investors and hedge funds.

About Cemex

CEMEX, SAB. de C.V. NYSE: CX is a global building materials company headquartered in Monterrey, Mexico. Its primary businesses include the production, distribution and sale of cement, ready-mix concrete and aggregates, which are used in residential, commercial and infrastructure construction.

The company also provides urbanization and building solutions, including paving materials, concrete products and related services intended to support construction projects from planning through completion.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.